Stem cell and neuroregeneration research at Johns Hopkins is taking on the most devastating neurologic illnesses with bold innovation and creativity. Identifying new successful treatments for brain cancer remains a challenging task. We ultimately aim for the ability to manipulate the microenvironments of these cells in order to find better therapies to fight brain cancer. Neural stem cells have been suggested to function as the primary precursors of new neurons. Most of our current knowledge on neurogenesis has come largely from rodent studies; it remains to be seen if this knowledge translates directly to human neurogenesis. 

Neurodegenerative diseases and traumatic brain injury have posed notoriously tough problems in management throughout history. At Johns Hopkins, real hope for future generations may be found in learning to coax remaining cells in the brain and nervous system to repair and replace injured or damaged cells. Collaborating with cell engineering and neuroregeneration experts, we are unlocking the mysteries of neuronal cell death and survival, apoptosis, cell fate specification, embryonic and adult stem cells, synapse formation, axonal and dendritic targeting, neuronal development, gene expression and the molecular biology of Parkinson’s disease, stroke and vision. Our discoveries are helping us push the field faster and closer toward clinical treatments. 

Manuscripts with relevance to the scope can be submitted to our Email: neurosci@eclinicalsci.com or editor.jnscr@scitechnol.com or Online Submission at Neuroscience

Author Information: Complete names and affiliation of all authors, including contact details of corresponding author (Telephone, Fax and E-mail address).

Thanks and Regards,
Peter K
Editorial Assistant
Journal of Neuroscience and Clinical Research
WhatsApp: +44-151-808-0171
Email: editor.jnscr@scitechnol.com